Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 10th May 2021
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Pig and cattle health projects receive funding boost
The funding will help to progress two projects focussing on pig and cattle health.
Two projects receive more than three million in funding to progress. 

Researchers at the Pirbright Institute have received €3.5 million in funding to proceed with two projects designed to improve the health of cattle and pigs.

The funding will be used to tackle three livestock viruses - bovine respiratory syncytial virus (BRSV) in cattle, and porcine reproductive and respiratory syndrome virus (PRRSV) and African swine fever virus (ASFV) in pigs. 

The first project, named NEOVACC, aims to develop vaccine strategies to improve the protection of newborn animals against BRSV and PRRS - the latter of which costs the global pig industry an estimated €1.5 billion a year. 

Professor Simon Graham said: “We are excited to begin work on the NEOVACC project. The consortium brings together a range of complementary expertise and knowledge to apply to our novel vaccine strategies, which we hope will provide young animals with enhanced protection against two important endemic diseases.” 

The second project, named ASFVInt, aims to identify the roles of around half of the 150-170 genes contained in the ASFV genome. This fatal pig disease was thought to have caused China US$141billion in direct economic losses in 2019 and continues to pose a risk to economies across the globe. 

Led by Pirbright’s Dr Chris Netherton, the project will see six partners receive €1.4 million to investigate 80 ASFV genes and decipher what they each do during infection. 
The team will use the data to see if there are specific genes that are important for replication or that the virus uses to avoid the pig immune response - research that could lead to the development of new antivirals or vaccines. 

Dr Chris Netherton said: “Control measures against ASFV are limited by our relatively poor understanding of how ASFV manipulates the host immune response. 

£The ASFVint project will help fill this gap by bringing together expertise from a range of disciplines brought by partners drawn from across Europe. Together we hope to build a road map which help uncover novel ways to combat this fascinating but dangerous virus.”

Become a member or log in to add this story to your CPD history

RCVS Knowledge appoints Veterinary Evidence editor-in-chief

News Story 1
 RCVS Knowledge has welcomed Professor Peter Cockcroft as editor-in-chief for Veterinary Evidence.

A world-renowned expert in evidence-based veterinary medicine, Prof Cockcroft will lead the strategic development and editorial quality of the open-access journal. He was previously in the role from 2017-2020.

Katie Mantell, CEO of RCVS Knowledge, said: "We are excited about the extensive knowledge of evidence-based veterinary medicine and clinical veterinary research that Peter brings, and we look forward to working with him over this next phase of the journal's development." 

Click here for more...
News Shorts
CVS Group hit by cyber attack

CVS Group, which owns more than 450 veterinary practices in the UK, has been hit by a cyber attack.

In a statement, the group said the incident involved unauthorised external access to a limited number of its IT systems. As soon as the attack was discovered, the group took its IT systems temporarily offline, causing 'considerable operational disruption'.

It has warned that the security steps taken and ongoing plans to move its operational systems and IT infrastructure to the Cloud are likely to have an ongoing impact over a number of weeks.

Due to the risk that personal information was accessed, CVS has informed the Information Commissioner's Office. The company is working with third party consultants to investigate the incident.